ART558 - Artios Pharma
Krazati (adagrasib) - BMS
BCCA7693 - adMare BioInnovations, BC Cancer Agency
Tafinlar (dabrafenib) - Novartis
Lynparza (olaparib) - Merck (MSD), AstraZeneca
Mekinist (trametinib) - Novartis, BeOne Medicines
Gilotrif (afatinib) - Boehringer Ingelheim
https://www.abstractsonline.com/pp8/#!/21436/presentation/11480
 
Alastair H. Kyle1; Judit P. Banath1; Sevin Teymori1; Ela Smiljanic-Hurley2; Simon Osborne2; Jay Paquette3; Steve Arns3; Claudio Sturino3; Joseph Mancini3; Andrew I. Minchinton1
 
Mar 18, 2026
 
Prev Next